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Abstract
Food allergy is a serious and potentially life-threatening problem for an estimated 6% of children
and 3.7% of adults. This review examines the diagnostic process that begins with a patient's history
and physical examination. If the suspicion of IgE-mediated food allergy is compelling based on the
history, skin and serology tests are routinely performed to provide confirmation for the presence
of food-specific IgE antibody. In selected cases, a provocation challenge may be required as a
definitive or gold standard reference test for confirmation of IgE mediated reactions to food.
Variables that influence the accuracy of each of the diagnostic algorithm phases are discussed. The
clinical significance of food allergen-specific IgE antibody cross-reactivity and IgE antibody epitope
mapping of food allergens is overviewed. The advantages and limitations of the various diagnostic
procedures are examined with an emphasis on future trends in technology and reagents.
Introduction
Approximately 6% of children and 3.7% of adults experi-
ence IgE-mediated allergic symptoms following the inges-
tion of food [1]. This contrasts with approximately 20% of
the population that alters their diet for a perceived adverse
reaction to food [2]. The allergist has the challenge of
accurately identifying immunologically and non-immu-
nologically-mediated reactions in the setting of this per-
ception using information provided by the patient's
history, skin and serology testing for food-specific IgE and
food challenges.
A number of general issues must be considered when
reviewing studies on the diagnosis of food allergy. These
considerations include the characteristics of the patient
population in individual studies, the instrumentation and
interpretation of allergen-specific IgE skin and serology
testing and variations in food challenge protocols [3].
This review examines the diagnostic process that begins
with a patient's history and physical examination. We will
overview considerations involved in skin testing and then
focus on specific IgE testing, which has become of para-
mount importance in both diagnosing and following the
natural history of food allergy. We highlight potential
problems with the "gold standard" of food allergy diagno-
sis, the double-blinded, placebo-controlled food chal-
lenge. We then review the importance of considering
cross-reactivity in the interpretation of skin testing and
specific-IgE testing while discussing new technologies that
may help decipher the degree of cross-reactivity. Finally,
we mention the experimental studies of food-allergen
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epitope mapping in predicting the natural history of milk
and egg allergy.
Clinical history
The patient's history and physical examination are the
foundation for the diagnosis of food allergy. The first goal
is to distinguish whether the patient's reaction has an
immunologic or a non-immunologic basis. Immunologic
reactions include immediate-type, IgE-mediated reactions
that involve the skin (pruritus, urticaria, angioedema,
flushing), GI tract (oral pruritus, nausea, vomiting,
diarrhea), nasal/respiratory tract (nasal congestion, rhin-
norhea, ocular pruritus, sneezing, nasal pruritus, laryngeal
edema, wheezing, shortness of breath) and/or the cardio-
vascular system (light-headedness, syncope, hypoten-
sion). These reactions can lead to death [4,5]. These
symptoms typically begin within an hour of ingestion of
the culprit food. The foods most commonly involved in
food allergy are cow's milk, hen's egg, peanuts, tree nuts,
seeds, soy, wheat, fish and crustaceans [6]. "Oral allergy
syndrome" is an IgE-mediated reaction to fresh fruit, and
less frequently nuts and vegetables, due to cross-reactivity
to aeroallergens such as birch tree pollen or ragweed that
cause oral pruritus, tingling and/or angioedema of the
lips, palate, tongue or oropharynx [7].
Other food-mediated immunological or non-immuno-
logical reactions have different history and physical exam-
ination features from immediate-type hypersensitivity
reactions. Conditions with both non-IgE and IgE based
mechanisms include eosinophilic gastrointestinal disor-
ders and atopic dermatitis. Types of cell-mediated food
hypersensitivity include food-induced enterocolitis, food-
induced pulmonary hemosiderosis (Heiner's syndrone),
celiac disease, contact dermatitis and dermatitis herpeti-
formis. Non-immunologic reactions include lactose intol-
erance or other problems with food digestion. This review
will focus on the diagnosis of immediate-type, IgE-medi-
ated food allergy.
Skin prick testing
In conjunction with the history and physical exam, diag-
nostic skin testing is a cornerstone in the evaluation of
food allergy. It offers an in-office, rapid, and sensitive
assessment of allergen sensitization.
General considerations of skin testing should be discussed
first before exploring the specific details of food allergen
skin testing. Extensive variability exists in skin prick test
devices, skin testing techniques used, and the grading and
interpretation of results [8-10]. Each variable needs to be
carefully considered before extrapolating the conclusions
from a published study to one's own clinical practice [10].
Inter-physician variation in scoring and interpretation of
skin tests is of particular concern in tests that are not
strongly positive or definitively negative [8].
Extending this discussion to food allergy, none of the food
extracts used in diagnostic skin testing have been stand-
ardized, and therefore, significant heterogeneity in aller-
genic protein content and variability in the ultimate
biological potency of these extracts often occurs between
lots. Fruits and vegetables produce extracts that contain
particularly labile allergens, and thus the use of fresh pro-
duce may offer increased sensitivity using the prick-prick
method [11]. Intradermal skin testing can also be associ-
ated with systemic reactions and it is generally not recom-
mended for the diagnosis of food allergy [12]. In one
study, no patient with a positive intradermal skin test and
a negative SPT to food had a positive double-blind pla-
cebo controlled food challenge (DBPCFC) [12].
Age must also be taken into account when assessing skin
test reactivity. Children younger than 2 years of age may
have less skin reactivity and thus smaller wheals than
older children. Children less than 1 year of age may have
IgE-mediated allergic disease related to a particular food
in the absence of skin test reactivity [13]
While the diagnostic sensitivity of negative puncture skin
test results is >95% in ruling out food allergy [2], its diag-
nostic specificity is limited. A larger puncture skin test
wheal size in conjunction with a positive clinical history
has been correlated with an increased likelihood of a pos-
itive open food challenge [14-17]. Specifically, using a
lancet puncture technique and an open food challenge for
confirmation, Sporik et al. demonstrated no negative
challenges if puncture skin test wheal sizes were ≥ 8 mm
for cow's milk or peanut and ≥ 7 mm for hen's egg [16].
Other studies have reported similar findings specifically
for hen's egg [18] and tree nut allergy [19].
Specific IgE testing
To date, the ImmunoCAP (Phadia, Uppsala, Sweden) has
been the only clinically used IgE antibody immunoassay
that has been systematically evaluated for its predictive
value in food allergy studies. Recent studies have shown
that the Immulite (Siemens Healthcare Diagnostics, Los
Angeles, CA, USA) may overestimate specific IgE measure-
ments in comparison to ImmunoCAP results [20,21].
Moreover, the Turbo RAST (currently HYTECH-288,
Hycor Biomedical-Agilent, Garden Grove, CA, USA)
reportedly overestimated egg-specific IgE but underesti-
mated IgE antibody levels to birch and D. farinae in
another study in comparison to the ImmunoCAP [20].
These data emphasize that the different clinically-used IgE
antibody autoanalyzers detect different populations of IgE
antibody.Allergy, Asthma & Clinical Immunology 2009, 5:2 http://www.aacijournal.com/content/5/1/2
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While the majority of research performed to date [1,2,21-
26] on the predictive power of quantitative food-specific
IgE antibody levels has been performed using the Immu-
noCAP System, it is likely that this is not the only assay
method that possesses the ability to predict individuals
who will experience positive food challenges. The research
to investigate the predictive power of other specific IgE
assays has simply not yet been performed. A 2008 Clinical
Laboratory Standards Institute consensus guideline on
quantitative IgE antibody methods [27] emphasizes that
each of the principal serological IgE antibody assays used
in clinical laboratories worldwide measures a different
population of IgE antibody for any given allergen specifi-
city. Thus, IgE antibody results generated with one
method should thus not be used to make predictive clini-
cal judgments with data in the literature generated using
another assay method [20,27]. The different quantitative
IgE antibody results among assays is most likely not the
result of an inherent assay design issue or their total IgE
calibration systems that are standardized to the same
World Health Organization 75/502 IgE reference prepara-
tion. Rather, these different IgE antibody results are more
likely to be a result of differential expression on allergenic
molecules/epitopes on the allergen-containing reagent in
each of these assays.
A new chip-based IgE antibody technology has emerged
to enhance the food allergen-specific IgE antibody data
that are available to both the clinician and the patient. The
microarray chip technology [28,29] has been commercial-
ized in the form of the ImmunoCAP-ISAC or Immuno
Solid phase Allergen Chip (VBC Genomics-Vienna, Aus-
tria; Phadia, Uppsala, Sweden). It currently has 103
native/recombinant component allergens from 43 aller-
gen sources that are dotted in triplicate onto glass slides.
Twenty microliters of serum are pipetted onto the chip
and antibodies specific for the allergens attached to the
chip surface bind during a 2 hour incubation period. Fol-
lowing a buffer wash, bound IgE is detected with a fluores-
cently-labeled anti-IgE. The chip is read in a fluorometer
and fluorescent signal units are interpolated into ISU or
ISAC units as semi-quantitative estimates of specific IgE
antibody in the original serum. The analytical sensitivity
of the ISAC varies as a function of the particular allergen
specificity and is generally viewed as less than the Immu-
noCAP system when the same allergens are coupled to
sponge allergosorbent. This device has been providing
clinical data to clinicians in Europe for several years, but
is not yet cleared by North American regulatory agencies
for clinical use.
Historically, specific IgE testing has been considered by
the allergist to be less sensitive than skin testing in the
diagnosis of food allergy [30]. However, during the 21st
century, serological measurements of food-specific IgE
antibody have become vital to the evaluation of food
allergy, especially in children. Serological IgE antibody
assays have the advantage of providing quantitative values
that can aid in predicting with high certainty the presence
of clinically significant food allergy, and thereby decreas-
ing the need for food challenges. While this has been
clearly demonstrated by Sampson and Ho [26] with the
ImmunoCAP, future work needs to be done to evaluate
the predictive cutpoints of the other IgE antibody assay
methods.
Food-specific IgE measurements on retrospectively evalu-
ated sera were used to develop 95% positive predictive
values for food allergy to milk, egg, peanut and fish in a
group of children with atopic dermatitis [26]. These cutoff
values were then confirmed in a prospective study of a
similar patient population to achieve 90% diagnostic spe-
cificity threshold values that can be used to avoid the need
for food challenge [25]. Predictive values for walnut have
also been developed [23]. Importantly, different predic-
tive values have emerged beyond the initial studies which
represent differences in diet, demographics (especially
age), disease states (e.g. presence or absence of atopic der-
matitis) of the study populations, and the challenge pro-
tocols (see Table 1). Therefore, it is critical to consider
these factors when extrapolating the clinical relevance of
the quantitative measures of IgE antibody. Specific IgE
values have also been used to determine the appropriate-
ness of a food challenge. For instance, a specific IgE level
of 2 kUa/L in a group of children with a high prevalence
of atopic dermatitis represented an approximately 50%
likelihood of passing a food challenge to milk, egg or pea-
nut [31]. This 50% likelihood is considered an acceptable
risk/benefit level for a food challenge [31].
In general, the magnitude of a food-specific IgE level can-
not predict the severity of the clinical reaction [32]. How-
ever, there was one recent report demonstrating a
significant correlation between the magnitude of specific
IgE and severity of clinical reaction in egg allergic chil-
dren. But there were a number of important exceptions to
this association [33]. An inverse relationship was reported
between the ratio of total peanut-specific IgE and chal-
lenge score to peanut allergy (r = -0.561) [34]. A study also
found that the food specific to total IgE ratio was no more
helpful than the specific IgE value in predicting the out-
come of a food challenge [35].
The allergen-specific IgE antibody level can also aid in pre-
dicting the natural history of allergies to peanut [36], tree
nuts [37], cow's milk [38] and hen's egg [39]. The rate of
decline of hen egg and cow's milk-specific IgE level can
help predict the resolution of the allergy [40].Allergy, Asthma & Clinical Immunology 2009, 5:2 http://www.aacijournal.com/content/5/1/2
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Food challenge
The DBPCFC has been long considered the "gold stand-
ard" for the diagnosis of food allergy and as a benchmark
test from which to judge the diagnostic performance char-
acteristics of the clinical history, skin test and IgE antibody
serology. Open challenges may have false positive results
ranging from 20.5-71% [41-43]. However, positive pla-
cebo reactions, that occur during the DBPCFC may be as
high as 35% [44,45]. False-negative open challenges occur
1-3% of the time [2]. Some authors argue that performing
several placebo and active oral provocations may be nec-
essary to increase the specificity of DBPCFC to ~95% [3].
The same authors and others [46,47] point out that the
general lack of standardized methods for the oral chal-
lenges is a primary limitation of the DBPCFC. Given a
reported placebo reaction rate of 27% in adults undergo-
ing oral drug challenge [48], oral food challenges in adults
may have similar limitations. In summary, these limita-
tions should be considered when estimating the overall
diagnostic performance of SPT and specific IgE antibody
testing.
Cross-reactivity
IgE antibody (immunological) cross-reactivity between
different foods or between food and aeroallergens such as
trees and grasses occurs much more readily than clinically
evident cross-reactivity. These immunological cross-reac-
tions, which are seen with both skin testing and serologi-
cal measures of IgE antibody, are generally reproducible
and effectively inhibited by soluble allergen. However,
they can often fail to translate into a clinical response fol-
lowing allergen exposure. Thus, a positive IgE antibody
response that is associated with a cross-reaction may be
considered a false positive result in relation to the sub-
Table 1: Comparison of studies reviewing the positive predictive values of food specific IgE testing.
Study No. 
subjects
% Atopic 
Dermatitis
Average 
Age 
(years)
Study design Food Total IgE 
median kU/
L(range)
PPV value %/
Specific IgE 
level
(kU/L)
Sens. for IgE 
level
Spec. for IgE 
level
Sampson HA 
and Ho DG 
[26]
196 100% 5.2 Retrospective
DBPCFC in 64%
Cow's milk 3000 
(100-40,000)
95%/32 51% 98%
Sampson HA 
[25]
62 61% 3.8 Prospective DBPCFC in 
34%
Cow's milk * 95%/15 57% 94%
Garcia-Ara C 
et al[58]
170 23% 0.4 Prospective open 
controlled challenge in 
95%
Cow'smilk * 95%/5 30% 99%
Celik-Bilgili S 
et al[22]
398 88% 1.1 Prospective DBPCFC or 
open challenge in all
Cow'smilk * 90%/88.8 * *
Sampson HA 
and Ho 
DG[26]
196 100% 5.2 Retrospective
DBPCFC in 64%
Hen's egg 3000 
(100-40,000)
95%/6 72% 90%
Sampson HA 
[25]
75 61% 3.8 Prospective DBPCFC in 
33%
Hen's egg * 98%/7 61% 95%
Celik-Bilgili S 
et al. [22]
227 88% 1.1 Prospective DBPCFC or 
open challenge in all
Hen's egg * 95%/12.6 * *
Boyano 
Martinez T et 
al. [61]
81 43% 1.3 Prospective, Open 
controlled challenge in all
Egg white 40(3-597) 94%/0.35 91% 77%
Osterballe M 
et al[62]
56 100% 2.2 Prospective, Open 
challenge in all
Egg white * 100%/1.5 60% 100%
Sampson HA 
and Ho DG 
[26]
196 100% 5.2 Retrospective
DBPCFC in 64%
Peanut 3000 
(100-40,000)
95%/15 73% 92%
Sampson 
HA[25]
68 61% 3.8 Prospective DBPCFC in 
2%
Peanut * 100%/14 57% 100%
Maloney JM et 
al[23]
234 57% 6.1 Prospective; clinical 
history, no challenges
Peanut * 99%/13 60% 96%
* Not providedAllergy, Asthma & Clinical Immunology 2009, 5:2 http://www.aacijournal.com/content/5/1/2
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ject's history of symptoms [49]. This further emphasizes
the fact that the simple presence IgE antibody is necessary
but not sufficient for clinical manifestation of allergic
symptoms. Other factors such as the affinity, epitope spe-
cificity (extent of cross-reactivity), concentration and spe-
cific IgE to total IgE ratio all contribute to whether effector
cells will degranulate following allergen exposure [50,51].
Patients, for example, who are sensitized to grass may
have positive skin test to wheat, even though there is no
evidence of clinical reactivity to the ingestion of wheat
[52]. Sicherer provides an excellent review on the cross
reactivity exhibited between foods [49].
Techniques to better understand the intricacies of cross
reactivity remain one of the great challenges in the accu-
rate laboratory diagnosis of food allergy. ISAC [28,29] is
one IgE antibody assay that is specifically designed to aid
the clinician in identifying the presence and quantifying
the degree cross-reactive IgE antibody among the different
food and pollen allergen groups that are known to share
extensive homology. Bet-v 1 from Birch tree pollen, for
instance, has structural homology in the PR10 family with
allergenic proteins from alder tree pollen (Aln-g 1), hazel-
nut pollen (Cor-a 1), apple (Mal-d 1), peach (Pru-p 1),
soybean (Gly-m 4), peanut (Ara-h 8), celery (Apr-g 1), car-
rot (Dau-c 1) and kiwi (Act-d 8). A primary sensitivity to
Bet-v 1 may result in oral allergy symptoms after exposure
to any of these other structurally similar (cross-reactive)
allergenic molecules. The ISAC chip also can aid in iden-
tifying cross-reactivity among other allergen families such
as the profilins (e.g., Bet-v 2-Birch, Ole-e 2-Olive, Hev-b 8-
Latex, Phi-p 12-timothy grass), the lipid transfer proteins
(e.g., Cor-a 9-hazelnut, Pru-p 3-peach, Art-v 3-mugwort
and Par-j 2-Wall pellitory), the calcium binding proteins
(e.g., Bet-v 4-birch, Phl-p 7-timothy grass), the tropomy-
osins (e.g, Pen-a 1-shrimp, Der-p 10-house dust mite, Bla-
g 7-cockroach, Ani s 3-Anisakis), and the serum albumin
family (e.g, Bos-d 6-bovine, Fel-d 2-cat, Can-f 3-dog, Equ-
c 3-Horse and Gal-d 5-chicken). Knowledge of the extent
of IgE cross-reactivity among these structurally similar
proteins provides unique information to the allergist as
support to the clinical history in diagnosis and manage-
ment of the food allergic patient [53]. Combined with
personal computer-based intelligent software algorithms
that aid the practicing allergy specialist in digesting and
interpreting the vast amount of IgE antibody data from
the chip-based microarray assay, the issue of food cross-
reactivity should become more manageable. One high
profile serological issue involving PR-10/Bet v 1 homo-
logue cross-reactivity is the recent supplementation of the
hazelnut Phadia ImmunoCAP allergosorbent with recom-
binant hazelnut Cor a 1 that is known to cross-react with
Birch Bet v 1 [54]. Following this supplementation, serum
from birch pollen allergic individuals containing IgE anti-
Bet v 1 produced high IgE anti-hazelnut levels in the
ImmunoCAP due to cross-reactivity. The clinical signifi-
cance of these levels has been questioned and some clini-
cians have returned to evaluating their patients for
hazelnut sensitivity using Cor a 1 unsupplemented hazel-
nut allergosorbents.
Epitope mapping in food allergy
Recent scientific advances have allowed for the identifica-
tion and cloning of specific food epitopes [55]. The iden-
tification of specific IgE epitopes with immunoblot
analyses may theoretically be used to better define the
likelihood of clinical reactivity and/or natural history of
food allergy than traditional allergen specific IgE measure-
ments as described above in the section on "specific IgE
testing" [55]. Special attention has been given to the
quantitative detection of linear versus conformational
food epitopes. One hypothesis is that conformational
epitopes on food allergens may degrade in the GI tract,
while linear epitopes retain their immunogenicity and
allergenicity even in the enzyme rich, acidic gut environ-
ment [55]. Thus, children who have IgE antibodies spe-
cific for linear epitopes to alpha-s-1 and beta-casein, for
instance, may be more likely to have persistent milk
allergy [56]. Caseins comprise 80% of milk proteins and
are composed of 4 protein fractions: αs1-, αs2-, β-, and κ-
caseins. Whey proteins comprise the remainder of milk
protein. The relative allergenicity of each cow's milk pro-
tein is unclear, although caseins seem to be the major
allergen [57] Likewise, children with persistent hen egg
allergy develop IgE antibodies against more sequential
and conformational epitopes of ovomucoid, the domi-
nant and most allergenic egg allergen, and ovalbumin
[58]. However, epitope mapping of peanut allergens has
not offered substantial clinical benefit over specific IgE
measurements for the assessment of peanut allergy
[59,60].
Summary
Diagnosis of IgE-mediated food allergy has progressed
over the last ten years. Threshold values for allergen-spe-
cific IgE have provided allergy specialists with a new diag-
nostic tool to define the need for a food challenge and
allowed greater insight into the natural history of allergic
reactions to selected foods. These IgE antibody threshold
values should be carefully used, however, while taking
into consideration the potential variability resulting from
differences in the study populations and the methods
used in provocation testing. Better definition of the IgE
cross-reactivity among foods and between foods and pol-
lens needs to be factored into the diagnostic process to
more accurately predict clinical reactivity. Furthermore,
use of recombinant and native purified allergenic mole-
cules in the micro-array chip-based ISAC assay for specific
IgE antibody should help clarify some common cross-
reactivity seen among foods. Finally, exploration of foodAllergy, Asthma & Clinical Immunology 2009, 5:2 http://www.aacijournal.com/content/5/1/2
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allergen epitope diversity and IgE avidity and specific
activity (specific to total IgE ratio) may allow for
improved diagnostic specificity.
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